MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on April 1, 2008; DOI: 10.1124/mol.108.046789


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.108.046789v1
74/1/132    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kuryatov, A.
Right arrow Articles by Lindstrom, J. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kuryatov, A.
Right arrow Articles by Lindstrom, J. M.


Received for publication February 29, 2008.
Revised March 26, 2008.
Accepted for publication March 31, 2008.

Roles of Accessory Subunits in {alpha}4{beta}2* Nicotinic Receptors

Alexander Kuryatov 1, Jennnifer Onksen 1, Jon M. Lindstrom 2*

1 University of Pennsylvania 2 University of Pennsylvania Medical School

* Address correspondence to: E-mail: jslkk{at}mail.med.upenn.edu

Abstract

Accessory subunits in heteromeric nicotinic receptors (AChRs) do not take part in forming ACh binding sites. {alpha}5 and {beta}3 subunits can function only as accessory subunits. We show that both {alpha}5 and {beta}3 efficiently assemble in human {alpha}4{beta}2* AChRs expressed in permanently transfected HEK cell lines. Only ({alpha}4{beta}2)2{alpha}5, not ({alpha}4{beta}2)2{beta}3 AChRs, have been detected in brain. The {alpha}4{beta}2{alpha}5 line expressed 40% more AChRs than the parent {alpha}4{beta}2 line, and was equally sensitive to upregulation by nicotine. The {alpha}4{beta}2{beta}3 line expressed 25 fold more AChRs than the parental line, and could not be further upregulated by nicotine. Relative sensitivity to activation by ACh depends on the accessory subunit, with {beta}2 conferring the greatest sensitivity, {alpha}5 less, and {beta}3 and {alpha}4 much less. Accessory subunits form binding sites for positive allosteric modulators, as illustrated by the observation that {alpha}5 conferred high sensitivity to galanthamine. In the presence of {alpha}5 or {beta}3, stable, partially degraded, dead end intermediates accumulated within the cells. These may have of the form {alpha}5{alpha}4{beta}2{alpha}5. The efficiency with which {alpha}5 and {beta}3 assemble with {alpha}4 and {beta}2, and the necessity of avoiding formation of potentially toxic intermediates, may explain why {alpha}5 and {beta}3 appear to be transcribed at low levels in brain. Autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE) can be caused by the {alpha}4 mutation S247F. This mutant did not produce functional AChRs unless cells were cotransfected with {alpha}5, {beta}3, or {alpha}6 to replace {alpha}4 as accessory subunit.


Key words: Nicotinic cholinergic, Func. analysis receptor/ion channel mutants, Receptor binding studies


This article has been cited by other articles:


Home page
J. Neurosci.Home page
S. M. Kassam, P. M. Herman, N. M. Goodfellow, N. C. Alves, and E. K. Lambe
Developmental Excitation of Corticothalamic Neurons by Nicotinic Acetylcholine Receptors
J. Neurosci., August 27, 2008; 28(35): 8756 - 8764.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2008 by the American Society for Pharmacology and Experimental Therapeutics